Skip to content

Company

C3J Therapeutics (United States)

Marina del Rey, United States · armatapharma.com

Part of Armata Pharmaceuticals (United States)

Manage this page

Citations, last 5 years: 3
Works, last 5 years: 2
h-index: 52
Scientists listed: 0
Grants since 2016: 5

Grants received

2017–2020 · research · R44

Clinical Development of JS-K for the Treatment of Cancer

Joseph Felix Nowoslawski · C3J Therapeutics (United States) · funded by National Institutes of Health

$999.4k

2017–2019 · research · R44

Clinical Development of JS-K for the Treatment of Cancer

Joseph Felix Nowoslawski · C3J Therapeutics (United States) · funded by National Institutes of Health

$999.2k

2015–2020 · research · R33

Towards the Development of Engineered Phage Therapeutics against MDR Pathogens

Elena M Barbu · C3J Therapeutics (United States) · funded by National Institutes of Health

$380.9kBacteriophages and microbial interactions

2015–2020 · research · R33

Towards the Development of Engineered Phage Therapeutics against MDR Pathogens

Elena M Barbu · C3J Therapeutics (United States) · funded by National Institutes of Health

$417.9kBacteriophages and microbial interactions

2015–2020 · research · R33

Towards the Development of Engineered Phage Therapeutics against MDR Pathogens

Sebastien Lemire · C3J Therapeutics (United States) · funded by National Institutes of Health

$367.3kBacteriophages and microbial interactions